"The newly proposed MMA allowed the team to find a few key VOCs that could reliably separate lung cancer cells (A549) from normal lung cells (BEAS-2B)," said Dr. Ge Dianlong, a member of the team.

We employed the CRISPR/Cas9 genome editing platform for the generation of the desired targeted genomic rearrangement in the A549 lung cancer cell line. Single guide RNAs (sgRNAs) designed and ...

Discover how combining photodynamic therapy (PDT) with cisplatin enhances lung cancer treatment, promoting tumor cell ...

The cell viability assay findings showed that the half-maximal effective concentration (EC50) values of All-Purple sweet potato leaf extracts were 0.013 µg/µl for lung cancer (A549) and 0.002 ...